Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             11 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Adenocarcinoma of Unknown Primary in a 20-Year-Old African American Male Power, Derek
2009
7 2 p. E45-E48
nvt p.
artikel
2 A Differential Response to Sunitinib: Sustained Systemic Response Paralleled by Intra-Dural Progression in the Spine. Should Standard Response Criteria Be Reviewed? Jafri, Mariam
2009
7 2 p. E42-E44
nvt p.
artikel
3 Do Patients With Advanced Urothelial Carcinoma Benefit From Weekly Paclitaxel Chemotherapy? A GETUG Phase II Study Joly, Florence
2009
7 2 p. E28-E33
nvt p.
artikel
4 Eosinophilic Rash Secondary to Temsirolimus Gandhi, Mona
2009
7 2 p. E34-E36
nvt p.
artikel
5 Influence of Demographic Factors on Outcome of Collecting Duct Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis Pepek, Joseph M.
2009
7 2 p. E24-E27
nvt p.
artikel
6 Neoadjuvant Sunitinib Facilitates Nephron-Sparing Surgery and Avoids Long-Term Dialysis in a Patient With Metachronous Contralateral Renal Cell Carcinoma Ansari, Jawaher
2009
7 2 p. E39-E41
nvt p.
artikel
7 New Therapeutic Agents for Castration-Refractory Prostate Cancer Patten, David Y.
2009
7 2 p. E4-E6
nvt p.
artikel
8 Predictive Value of Urinary Interleukin-8 Cutoff Point for Recurrences After Transurethral Resection Plus Induction Bacillus Calmette-Guérin Treatment in Non–Muscle-Invasive Bladder Tumors Sagnak, Levent
2009
7 2 p. E16-E23
nvt p.
artikel
9 Reversal of Docetaxel Resistance With Bevacizumab and Thalidomide Ning, Yang-min
2009
7 2 p. E37-E38
nvt p.
artikel
10 Safety and Efficacy of Sorafenib Therapy in Patients With Metastatic Kidney Cancer With Impaired Renal Function Parsa, Venkata
2009
7 2 p. E10-E15
nvt p.
artikel
11 The High-Dose Aldesleukin (IL-2) “Select” Trial: A Trial Designed to Prospectively Validate Predictive Models of Response to High-Dose IL-2 Treatment in Patients With Metastatic Renal Cell Carcinoma Clement, Jessica M.
2009
7 2 p. E7-E9
nvt p.
artikel
                             11 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland